Pfizer Seeks Full FDA Approval for Oral COVID-19 Therapy Paxlovid
Pfizer is jockeying for full FDA approval of its oral antiviral COVID-19 treatment, Paxlovid, which would allow the company to sell the drug commercially.
Source: Drug Industry Daily
Pfizer is jockeying for full FDA approval of its oral antiviral COVID-19 treatment, Paxlovid, which would allow the company to sell the drug commercially.
Source: Drug Industry Daily